Literature DB >> 31662441

ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells.

Glenn P Murray1, Steven R Post1, Ginell R Post2.   

Abstract

ABO blood group antigens are expressed on von Willebrand factor (VWF) and glycosylation patterns influence circulating VWF levels. The aim of this study was to examine the effect of ABO blood type on tissue-associated VWF protein levels. We selected 35 formalin-fixed paraffin-embedded pulmonary tissue blocks obtained at autopsy from decedents who died from pulmonary embolism with known ABO blood groups (O, A, B and AB phenotypes), prepared tissue microarrays (TMAs) and stained TMAs with antibodies to VWF and platelet/endothelial cell adhesion marker-1 (PECAM-1) as a marker of endothelial cells. A pixel count scoring algorithm was used to quantify VWF and PECAM-1 staining intensity in pulmonary arterioles in digitised images. Compared with type O, non-O individuals have a significantly higher amount of endothelial cell-associated VWF protein expression. VWF protein levels associated with pulmonary vascular endothelial cells is influenced by ABO antigenic determinants. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ABO blood group; endothelial cell; von Willebrand factor

Year:  2019        PMID: 31662441     DOI: 10.1136/jclinpath-2019-206182

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  A1B and BB blood group genotypes are risk factors for pulmonary embolism.

Authors:  Tatjana Kereš; Irena Jukić; Tomo Svaguša; Ingrid Prkačin; Jasna Bingulac-Popović; Matea Vinković; Ana Hećimović; Marcela Živković; Nikolina Parašilovac
Journal:  Wien Klin Wochenschr       Date:  2021-06-03       Impact factor: 1.704

2.  An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.

Authors:  Liuyang Wang; Thomas J Balmat; Alejandro L Antonia; Florica J Constantine; Ricardo Henao; Thomas W Burke; Andy Ingham; Micah T McClain; Ephraim L Tsalik; Emily R Ko; Geoffrey S Ginsburg; Mark R DeLong; Xiling Shen; Christopher W Woods; Elizabeth R Hauser; Dennis C Ko
Journal:  Genome Med       Date:  2021-05-17       Impact factor: 15.266

3.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

Authors:  David Ellinghaus; Frauke Degenhardt; Luis Bujanda; Maria Buti; Agustín Albillos; Pietro Invernizzi; Javier Fernández; Daniele Prati; Guido Baselli; Rosanna Asselta; Marit M Grimsrud; Chiara Milani; Fátima Aziz; Jan Kässens; Sandra May; Mareike Wendorff; Lars Wienbrandt; Florian Uellendahl-Werth; Tenghao Zheng; Xiaoli Yi; Raúl de Pablo; Adolfo G Chercoles; Adriana Palom; Alba-Estela Garcia-Fernandez; Francisco Rodriguez-Frias; Alberto Zanella; Alessandra Bandera; Alessandro Protti; Alessio Aghemo; Ana Lleo; Andrea Biondi; Andrea Caballero-Garralda; Andrea Gori; Anja Tanck; Anna Carreras Nolla; Anna Latiano; Anna Ludovica Fracanzani; Anna Peschuck; Antonio Julià; Antonio Pesenti; Antonio Voza; David Jiménez; Beatriz Mateos; Beatriz Nafria Jimenez; Carmen Quereda; Cinzia Paccapelo; Christoph Gassner; Claudio Angelini; Cristina Cea; Aurora Solier; David Pestaña; Eduardo Muñiz-Diaz; Elena Sandoval; Elvezia M Paraboschi; Enrique Navas; Félix García Sánchez; Ferruccio Ceriotti; Filippo Martinelli-Boneschi; Flora Peyvandi; Francesco Blasi; Luis Téllez; Albert Blanco-Grau; Georg Hemmrich-Stanisak; Giacomo Grasselli; Giorgio Costantino; Giulia Cardamone; Giuseppe Foti; Serena Aneli; Hayato Kurihara; Hesham ElAbd; Ilaria My; Iván Galván-Femenia; Javier Martín; Jeanette Erdmann; Jose Ferrusquía-Acosta; Koldo Garcia-Etxebarria; Laura Izquierdo-Sanchez; Laura R Bettini; Lauro Sumoy; Leonardo Terranova; Leticia Moreira; Luigi Santoro; Luigia Scudeller; Francisco Mesonero; Luisa Roade; Malte C Rühlemann; Marco Schaefer; Maria Carrabba; Mar Riveiro-Barciela; Maria E Figuera Basso; Maria G Valsecchi; María Hernandez-Tejero; Marialbert Acosta-Herrera; Mariella D'Angiò; Marina Baldini; Marina Cazzaniga; Martin Schulzky; Maurizio Cecconi; Michael Wittig; Michele Ciccarelli; Miguel Rodríguez-Gandía; Monica Bocciolone; Monica Miozzo; Nicola Montano; Nicole Braun; Nicoletta Sacchi; Nilda Martínez; Onur Özer; Orazio Palmieri; Paola Faverio; Paoletta Preatoni; Paolo Bonfanti; Paolo Omodei; Paolo Tentorio; Pedro Castro; Pedro M Rodrigues; Aaron Blandino Ortiz; Rafael de Cid; Ricard Ferrer; Roberta Gualtierotti; Rosa Nieto; Siegfried Goerg; Salvatore Badalamenti; Sara Marsal; Giuseppe Matullo; Serena Pelusi; Simonas Juzenas; Stefano Aliberti; Valter Monzani; Victor Moreno; Tanja Wesse; Tobias L Lenz; Tomas Pumarola; Valeria Rimoldi; Silvano Bosari; Wolfgang Albrecht; Wolfgang Peter; Manuel Romero-Gómez; Mauro D'Amato; Stefano Duga; Jesus M Banales; Johannes R Hov; Trine Folseraas; Luca Valenti; Andre Franke; Tom H Karlsen
Journal:  N Engl J Med       Date:  2020-06-17       Impact factor: 91.245

4.  Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complications.

Authors:  Tosti J Mankelow; Belinda K Singleton; Pedro L Moura; Christian J Stevens-Hernandez; Nicola M Cogan; Gyongyver Gyorffy; Sabine Kupzig; Luned Nichols; Claire Asby; Jennifer Pooley; Gabriella Ruffino; Faroakh Hosseini; Fiona Moghaddas; Marie Attwood; Alan Noel; Alex Cooper; David T Arnold; Fergus Hamilton; Catherine Hyams; Adam Finn; Ashley M Toye; David J Anstee
Journal:  EJHaem       Date:  2021-04-02

5.  Implications of AB0 blood group in hypertensive patients with covid-19.

Authors:  Celestino Sardu; Raffaele Marfella; Paolo Maggi; Vincenzo Messina; Paolo Cirillo; Vinicio Codella; Jessica Gambardella; Antonio Sardu; Gianluca Gatta; Gaetano Santulli; Giuseppe Paolisso
Journal:  BMC Cardiovasc Disord       Date:  2020-08-14       Impact factor: 2.298

6.  Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.

Authors:  Donato Gemmati; Veronica Tisato
Journal:  Genes (Basel)       Date:  2020-09-03       Impact factor: 4.096

Review 7.  Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.

Authors:  S Amor; L Fernández Blanco; D Baker
Journal:  Clin Exp Immunol       Date:  2020-10-12       Impact factor: 4.330

Review 8.  Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.

Authors:  Cleo Anastassopoulou; Zoi Gkizarioti; George P Patrinos; Athanasios Tsakris
Journal:  Hum Genomics       Date:  2020-10-22       Impact factor: 4.639

9.  The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19.

Authors:  Ryan L Hoiland; Nicholas A Fergusson; Anish R Mitra; Donald E G Griesdale; Dana V Devine; Sophie Stukas; Jennifer Cooper; Sonny Thiara; Denise Foster; Luke Y C Chen; Agnes Y Y Lee; Edward M Conway; Cheryl L Wellington; Mypinder S Sekhon
Journal:  Blood Adv       Date:  2020-10-27

10.  Implications of ABO blood group in hypertensive patients with covid-19.

Authors:  Celestino Sardu; Raffaele Marfella; Paolo Maggi; Vincenzo Messina; Paolo Cirillo; Vinicio Codella; Jessica Gambardella; Antonio Sardu; Gianluca Gatta; Gaetano Santulli; Giuseppe Paolisso
Journal:  Res Sq       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.